EE04678B1 - Karbapeneemhend, selle stabiliseerimismeetod ja stabiliseeritud vorm ning farmatseutiline kompositsioon - Google Patents

Karbapeneemhend, selle stabiliseerimismeetod ja stabiliseeritud vorm ning farmatseutiline kompositsioon

Info

Publication number
EE04678B1
EE04678B1 EE9800022A EE9800022A EE04678B1 EE 04678 B1 EE04678 B1 EE 04678B1 EE 9800022 A EE9800022 A EE 9800022A EE 9800022 A EE9800022 A EE 9800022A EE 04678 B1 EE04678 B1 EE 04678B1
Authority
EE
Estonia
Prior art keywords
pharmaceutical composition
stabilization
stabilized form
carbapenem compound
compound
Prior art date
Application number
EE9800022A
Other languages
English (en)
Estonian (et)
Other versions
EE9800022A (et
Inventor
A. Zimmerman Jeffrey
M. Williams John
A. Bergquist Paul
M. Dimichele Lisa
C. Dubost David
J. Kaufman Michael
R. Sidler Daniel
A. Hunke William
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE04678(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9612668.5A external-priority patent/GB9612668D0/en
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of EE9800022A publication Critical patent/EE9800022A/xx
Publication of EE04678B1 publication Critical patent/EE04678B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EE9800022A 1996-05-28 1997-05-23 Karbapeneemhend, selle stabiliseerimismeetod ja stabiliseeritud vorm ning farmatseutiline kompositsioon EE04678B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1851896P 1996-05-28 1996-05-28
GBGB9612668.5A GB9612668D0 (en) 1996-06-18 1996-06-18 Carbapenem antibiotic composition and method of preparation
PCT/US1997/008831 WO1997045430A1 (en) 1996-05-28 1997-05-23 Carbapenem antibiotic, composition and method of preparation

Publications (2)

Publication Number Publication Date
EE9800022A EE9800022A (et) 1998-08-17
EE04678B1 true EE04678B1 (et) 2006-08-15

Family

ID=26309530

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800022A EE04678B1 (et) 1996-05-28 1997-05-23 Karbapeneemhend, selle stabiliseerimismeetod ja stabiliseeritud vorm ning farmatseutiline kompositsioon

Country Status (34)

Country Link
EP (1) EP0863901B1 (id)
JP (2) JPH11509871A (id)
KR (2) KR100403497B1 (id)
CN (1) CN1067074C (id)
AT (1) ATE252584T1 (id)
AU (1) AU710102B2 (id)
BG (1) BG63821B1 (id)
CA (1) CA2227994C (id)
CO (1) CO4940412A1 (id)
CY (1) CY2437B1 (id)
CZ (1) CZ296381B6 (id)
DE (1) DE69725696T2 (id)
DK (1) DK0863901T3 (id)
DZ (1) DZ2242A1 (id)
EA (1) EA000534B1 (id)
EE (1) EE04678B1 (id)
ES (1) ES2208907T3 (id)
HK (1) HK1016176A1 (id)
HR (1) HRP970281B1 (id)
HU (1) HU229426B1 (id)
ID (1) ID16974A (id)
IL (1) IL123078A (id)
IS (1) IS2353B (id)
MX (1) MX9800808A (id)
NO (1) NO323815B1 (id)
NZ (1) NZ329649A (id)
PL (1) PL188917B1 (id)
PT (1) PT863901E (id)
RS (1) RS49583B (id)
SI (1) SI0863901T1 (id)
SK (1) SK284359B6 (id)
TR (1) TR199800146T1 (id)
TW (1) TW434014B (id)
WO (1) WO1997045430A1 (id)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2268820A1 (en) * 1996-10-28 1998-05-07 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
ATE254127T1 (de) * 1997-06-16 2003-11-15 Merck & Co Inc Stabilisierte carbapenem-zwischenprodukteund ihre verwendung in der synthese
US6180783B1 (en) * 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
EP1244444B1 (en) * 1999-10-29 2004-12-29 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
AR035728A1 (es) 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
CN101357918B (zh) * 2007-06-22 2011-05-18 山东轩竹医药科技有限公司 含有异硫脲基巯基吡咯烷的培南衍生物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
JPWO2009075309A1 (ja) 2007-12-12 2011-04-28 大日本住友製薬株式会社 製剤組成物
CN101550138B (zh) * 2008-04-03 2011-05-18 山东轩竹医药科技有限公司 巯基氮杂环烷酰胺醇取代的培南衍生物
EP2505191A1 (en) * 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Lyophilized Carbapenem antibiotic composition
CN102365266B (zh) 2009-03-31 2013-11-06 三菱综合材料株式会社 含氟n-烷基磺酰亚胺化合物及其制造方法、以及离子性化合物的制造方法
CN102803649A (zh) 2009-06-25 2012-11-28 国际壳牌研究有限公司 注水系统和方法
US8889384B2 (en) 2010-10-07 2014-11-18 Shell Oil Company Process for the production of alcohols from biomass
AU2011323322B2 (en) 2010-11-05 2015-03-12 Shell Internationale Research Maatschappij B.V. Treating biomass to produce materials useful for biofuels
US8609379B2 (en) 2010-12-20 2013-12-17 Shell Oil Company Process for the production of alcohols from biomass
AU2012352235B2 (en) 2011-12-15 2015-01-15 Shell Internationale Research Maatschappij B.V. Method of treating byproducts from ethanol production
JP2015523061A (ja) 2012-05-17 2015-08-13 シエル・インターナシヨネイル・リサーチ・マーチヤツピイ・ベー・ウイＳｈｅｌｌ Ｉｎｔｅｒｎａｔｉｏｎａｌｅ Ｒｅｓｅａｒｃｈ Ｍａａｔｓｃｈａｐｐｉｊ Ｂｅｓｌｏｔｅｎｖｅｎｎｏｏｔｓｈａｐ バイオマス材料を処理する方法およびシステム
CN103860485A (zh) * 2012-12-18 2014-06-18 深圳市海滨制药有限公司 一种厄他培南钠冻干制剂及其制备方法
WO2015160887A1 (en) 2014-04-17 2015-10-22 Shell Oil Company Processes for producing fermentation products
WO2016025678A1 (en) 2014-08-14 2016-02-18 Shell Oil Company Process for preparing furfural from biomass

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds

Also Published As

Publication number Publication date
ATE252584T1 (de) 2003-11-15
DE69725696T2 (de) 2004-07-29
EA199800180A1 (ru) 1998-08-27
HUP9901567A2 (hu) 1999-09-28
PL188917B1 (pl) 2005-05-31
BG102273A (bg) 1998-09-30
CA2227994C (en) 2002-06-25
AU3077597A (en) 1998-01-05
PL324746A1 (en) 1998-06-08
TR199800146T1 (xx) 1998-06-22
RS49583B (sr) 2007-04-10
IS4663A (is) 1998-01-27
EP0863901A1 (en) 1998-09-16
ES2208907T3 (es) 2004-06-16
CZ296381B6 (cs) 2006-03-15
NO323815B1 (no) 2007-07-09
ID16974A (id) 1997-11-27
JPH11509871A (ja) 1999-08-31
PT863901E (pt) 2004-02-27
KR100344479B1 (ko) 2002-10-31
SK10998A3 (en) 1998-08-05
HU229426B1 (en) 2013-12-30
NO980380L (no) 1998-03-16
JP2009084284A (ja) 2009-04-23
NO980380D0 (no) 1998-01-28
NZ329649A (en) 1998-11-25
SI0863901T1 (en) 2004-04-30
CO4940412A1 (es) 2000-07-24
YU4198A (sh) 1998-12-23
CA2227994A1 (en) 1997-12-04
HRP970281B1 (en) 2002-04-30
CN1067074C (zh) 2001-06-13
HK1016176A1 (en) 1999-10-29
EP0863901B1 (en) 2003-10-22
KR100403497B1 (ko) 2003-10-30
IL123078A (en) 2002-03-10
CY2437B1 (en) 2004-11-12
SK284359B6 (sk) 2005-02-04
CZ25398A3 (cs) 1998-07-15
HRP970281A2 (en) 1998-06-30
TW434014B (en) 2001-05-16
KR19990036052A (id) 1999-05-25
BG63821B1 (bg) 2003-02-28
IL123078A0 (en) 1998-09-24
MX9800808A (es) 1998-04-30
DZ2242A1 (fr) 2002-12-18
EA000534B1 (ru) 1999-10-28
DK0863901T3 (da) 2004-02-16
IS2353B (is) 2008-04-15
CN1198162A (zh) 1998-11-04
HUP9901567A3 (en) 2000-03-28
EE9800022A (et) 1998-08-17
WO1997045430A1 (en) 1997-12-04
JP5255983B2 (ja) 2013-08-07
AU710102B2 (en) 1999-09-16
DE69725696D1 (de) 2003-11-27

Similar Documents

Publication Publication Date Title
EE04678B1 (et) Karbapeneemhend, selle stabiliseerimismeetod ja stabiliseeritud vorm ning farmatseutiline kompositsioon
AU6645998A (en) Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
MX9707980A (es) Derivados de 4-aminoquinazolina, composiciones que los contienen, y uso de los mismos.
AU2002211216A1 (en) Substituted aminopropoxyaryl derivatives useful as agonists for lxr
AU4064597A (en) Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
IS2648B (is) Amínósýklóhexýletersambönd og notkun þeirra
EP1153924A3 (en) Substituted 1,3-oxathiolanes with antiviral properties
YU41199A (sh) Hinoksalindioni
ATE224358T1 (de) Diaminocyclobuten-3,4-dionderivate, deren herstellung und deren verwendung
ZA974573B (en) Carbapenem antibiotic, composition and method of preparation.
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
MY116202A (en) Carbapenem antibiotic, composition and method of preparation
ECSP972136A (es) Composicion y metodo de preparacion de un antibiotico de carbapemen
MXPA99003849A (es) Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

HC1A Change of owner name